ATEA PHARMACEUTICALS, INC.
Profile
Company Names
ATEA PHARMACEUTICALS, INC.
Addresses
125 SUMMER ST., 16TH FLOOR, BOSTON, MA 02110
125 SUMMER STREET, 16TH FL, BOSTON, MA 02110
125 SUMMER STREET, BOSTON, MA 02110
Phone Numbers
857-204-8109
857-284-8891
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$175,929,650.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-05-19
$107,499,941.00
$214,999,608.00
$107,499,667.00
Equity
3
2018-06-29
$27,599,934.00
$27,599,934.00
$0.00
Equity
2
2016-08-29
$20,829,775.00
$20,829,775.00
$0.00
Equity
1
2013-12-30
$20,000,000.00
$20,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLIN
BERGER
DIRECTOR
FIVE PRIME THERAPEUTICS INC
| ITHERX PHARMA, INC.
| IMMUNE DESIGN CORP.
| ALZHEON, INC.
| ATRECA, INC.
| ESSA PHARMA INC.
| CERUS ENDOVASCULAR LTD
| KEZAR LIFE SCIENCES, INC.
| BELLUS HEALTH INC.
| APPLIED THERAPEUTICS INC.
| ATEA PHARMACEUTICALS, INC.
| RAIN THERAPEUTICS INC.
| WALKING FISH THERAPEUTICS, INC.
| SATELLOS BIOSCIENCE INC.
GRIGORY
BORISENKO
DIRECTOR
GERALD
CHAN
DIRECTOR
CRITICAL BIOLOGICS CORP
| MORNINGSIDE CHINA TMT FUND II, L.P.
| SYNCHRONEURON INC.
| NATURAL POLYMER INTERNATIONAL CORP
| APELLIS PHARMACEUTICALS, INC.
| MORNINGSIDE CHINA TMT FUND III CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND, L.P.
| MORNINGSIDE CHINA TMT FUND III, L.P.
| MORNINGSIDE CHINA TMT TOP UP FUND LP
| MORNINGSIDE CHINA TMT FUND IV CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P.
| MORNINGSIDE CHINA TMT FUND IV, L.P.
| ATEA PHARMACEUTICALS, INC.
| GOOD FOODIE CO
| KEZAR LIFE SCIENCES, INC.
| APNIMED, INC.
| STAVROS TECHNOLOGIES, INC.
| STEALTH BIOTHERAPEUTICS CORP
| LUMIRADX LTD
| LINUS HEALTH, INC.
| ANACONDA, INC.
| NEUTROLIS INC.
| COGNITO THERAPEUTICS LTD.
| COGNITO THERAPEUTICS GROUP, INC.
BIHUA
CHEN
DIRECTOR
CORMORANT GLOBAL HEALTHCARE FUND, LP
| CORMORANT GLOBAL HEALTHCARE OFFSHORE FUND, LTD.
| APELLIS PHARMACEUTICALS, INC.
| C4 THERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE FUND I, LP
| TP THERAPEUTICS, INC.
| TP THERAPEUTICS, INC
| KEZAR LIFE SCIENCES, INC.
| ATEA PHARMACEUTICALS, INC.
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND II, LP
| CORMORANT PRIVATE HEALTHCARE FUND II, LP
| ATIA VISION, INC.
| SUPIRA MEDICAL, INC.
| CORMORANT PRIVATE HEALTHCARE FUND III LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND III LP
| ADONA MEDICAL, INC.
| BLOSSOMHILL THERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND IV LP
| CORMORANT PRIVATE HEALTHCARE FUND IV LP
| TIOGA CARDIOVASCULAR, INC.
| BIVACOR INC.
| CHROMA MEDICINE, INC.
| BIOVENTRIX INC
| TIGER BIOTHERAPEUTICS INC.
| CORMORANT PRIVATE HEALTHCARE FUND V LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND V LP
| GRAVITON BIOSCIENCE CORP
| INTERIUS BIOTHERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE FUND VI, LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND VI, LP
| AKURA MEDICAL, INC.
JEAN-PIERRE
SOMMADOSSI
EXECUTIVE OFFICER, DIRECTOR
JEAN-PIERRE
SOMMADOSSI, PH.D.
EXECUTIVE OFFICER, DIRECTOR
FAN
YU
DIRECTOR
THEMES INVESTMENT PARTNERS II, L.P.
| LONESTAR HEART, INC.
| SONENDO, INC.
| ABG INNOVATION TEAM, L.P.
| ALLY BRIDGE GROUP INNOVATION CAPITAL PARTNERS III, L.P.
| ATEA PHARMACEUTICALS, INC.
| ALLY BRIDGE GROUP-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS, L.P.
| IMPERATIVE CARE, INC.
| SONOMA BIOTHERAPEUTICS, INC.
| ALLY BRIDGE MEDALPHA INTERNATIONAL FUND LTD
| SHORELINE BIOSCIENCES, INC.
| ALLY BRIDGE GROUP GLOBAL LIFE SCIENCE CAPITAL PARTNERS V, L.P.
| ABG V TEAM, L.P.
| ABG-SIV II, L.P.
| ABG-MAINSTAY L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
